Loading clinical trials...
Loading clinical trials...
A Phase III Study to Evaluate Long-Acting Antiretroviral Therapy in Non-Adherent HIV-Infected Individuals
Conditions
Interventions
Standard of Care (SOC) Oral ART
Oral RPV
+5 more
Locations
33
United States
Alabama CRS
Birmingham, Alabama, United States
University of Southern California CRS
Los Angeles, California, United States
UCLA CARE Center CRS
Los Angeles, California, United States
UCSD Antiviral Research Center CRS
San Diego, California, United States
Ucsf Hiv/Aids Crs
San Francisco, California, United States
Harbor-UCLA CRS
Torrance, California, United States
Start Date
March 28, 2019
Primary Completion Date
February 12, 2024
Completion Date
August 30, 2026
Last Updated
September 2, 2025
NCT06627764
NCT04142047
NCT06694805
NCT05398185
NCT07428330
NCT07225530
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions